Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumor necrosis factor-alpha.

× No keyword cloud information.

11 in total

1. Increased distribution and expression of CD64 on blood polymorphonuclear cells from patients with the systemic inflammatory response syndrome (SIRS).

Authors: S S Qureshi; S M Lewis; V A Gant; D Treacher; B H Davis; K A Brown
Journal: Clin Exp Immunol Date: 2001-08 Impact factor: 4.330

2. Prostacyclin counteracts the increase in capillary permeability induced by tumour necrosis factor-alpha.

Authors: J Jahr; P O Grände
Journal: Intensive Care Med Date: 1996-12 Impact factor: 17.440

Review 3. Septic shock: pathogenesis and treatment.

Authors: L Castillo; M Sanchez
Journal: Indian J Pediatr Date: 1993 May-Jun Impact factor: 1.967

4. Tumor necrosis factor-alpha blockade prevents neutrophil CD18 receptor upregulation and attenuates acute lung injury in porcine sepsis without inhibition of neutrophil oxygen radical generation.

Authors: A C Windsor; C J Walsh; P G Mullen; D J Cook; B J Fisher; C R Blocher; S K Leeper-Woodford; H J Sugerman; A A Fowler
Journal: J Clin Invest Date: 1993-04 Impact factor: 14.808

5. Tumor necrosis factor stimulates amino acid transport in plasma membrane vesicles from rat liver.

Authors: A J Pacitti; Y Inoue; W W Souba
Journal: J Clin Invest Date: 1993-02 Impact factor: 14.808

6. Accelerated hepatic arginine transport in the tumor-bearing rat.

Authors: N J Espat; E M Copeland; W W Souba
Journal: Ann Surg Oncol Date: 1994-03 Impact factor: 5.344

7. Repeat application of microneedles does not alter skin appearance or barrier function and causes no measurable disturbance of serum biomarkers of infection, inflammation or immunity in mice in vivo.

Authors: Eva M Vicente-Perez; Eneko Larrañeta; Maelíosa T C McCrudden; Adrien Kissenpfennig; Shauna Hegarty; Helen O McCarthy; Ryan F Donnelly
Journal: Eur J Pharm Biopharm Date: 2017-05-03 Impact factor: 5.571

8. Frailty as an Outcome Predictor After Ankle Fractures: Where Are We Now?

Authors: Mohamed Mediouni; Daniel R Schlatterer
Journal: Geriatr Orthop Surg Rehabil Date: 2018-11-15

9. Structure-Based Virtual Screening of Tumor Necrosis Factor-α Inhibitors by Cheminformatics Approaches and Bio-Molecular Simulation.

Authors: Sobia Ahsan Halim; Almas Gul Sikandari; Ajmal Khan; Abdul Wadood; Muhammad Qaiser Fatmi; René Csuk; Ahmed Al-Harrasi
Journal: Biomolecules Date: 2021-02-22

Review 10. Are Mesenchymal Stem Cells able to manage Cytokine Storm in COVID-19 patients? A review of recent studies.

Authors: Najmeh Kaffash Farkhad; Hamidreza Reihani; Alireza Sedaghat; Amir Adhami Moghadam; Ahmad Bagheri Moghadam; Jalil Tavakol-Afshari
Journal: Regen Ther Date: 2021-06-08 Impact factor: 3.419